Stimuliver
Joakim Nguyen Sørensen is a COO at Stimuliver and Notify Therapeutics. Joakim is also a Biopharm Market Consultant at Soerensen Life Science Consulting, specializing in market analysis and strategy for early stage life science start-ups. Previous roles include COO at Bainan Biotech, BD Project Manager, and Assistant to the Executive Director at Synklino. Additionally, Joakim has experience as an Assistant Lecturer at the University of Copenhagen and as a Student Assistant at Region Hovedstadens Psykiatri. Joakim holds a MSc in Business Administration and Innovation in Health Care from Copenhagen Business School and a Bachelor of Public Health Science from Københavns Universitet - University of Copenhagen.
This person is not in any teams
Stimuliver
Liver disease kills approximately two million people per annum. Although organ transplant is a viable option to treat disease, many patients are not candidates for this type of treatment or die on the transplant waiting list. Stimuliver is developing a disruptive liver implant to treat critically failing liver function in humans. The implant will be placed underneath the skin to ‘top up’ the patient’s reduced liver function. Lab engineered liver tissue will be produced from human stem cells, providing a scalable and renewable source of human liver tissue. The development of the liver implant to clinical grade will provide patients with a renewable treatment option for their disease.